First human tests begin for new drug candidate
NCT ID NCT06895343
Summary
This early-stage study aims to check the safety and basic effects of a new drug called ABBV-701 in healthy people. It will involve about 100 healthy adults from Western and Asian backgrounds. Researchers will give participants different single doses to see how the drug moves through the body and if it causes any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Acpru /Id# 273354
Grayslake, Illinois, 60030, United States
-
CenExel ACT- Anaheim Clinical Trials /ID# 278431
Anaheim, California, 92801, United States
Conditions
Explore the condition pages connected to this study.